Group items tagged

i diagnosed with HIV at birth and immediately put on antiretroviral therapy.

brought back into care at 23 months, despite being off treatment for five months, the child was found to have an undetectable viral load

d today no signs of HIV infection in the child can be detected by the most sensitive means available.

Doctors in the US have made medical history by effectively curing a child born with HIV, the first time such a case has been documented.

Dr Hannah Gay, who cared for the child at the University of Mississippi medical centre, told the Guardian the case amounted to the first "functional cure" of an HIV-infected child.

but it is likely that a tiny amount remains in their body.

ee venom contains a potent toxin called melittin that can poke holes in the protective envelope that surrounds HIV

When the nanoparticles come into contact with normal cells, which are much larger in size, the particles simply bounce off

an advantage of this approach is that the nanoparticle attacks an essential part of the virus' structure. In contrast, most anti-HIV drugs inhibit the virus's ability to replicate

"After mosquito spraying programs were cut, we've seen a return of malaria, which the country has kept under control for the past four decades. New HIV infections have jumped more than 200 percent," he noted.

"Greece is an example of perhaps the worst case of austerity leading to public health disasters," Mr. Stuckler explained in a telephone interview.

HIV spiked because government needle exchange programs ran out of clean syringes for heroin addicts. By Stuckler's estimate, the average Greek junkie requires 200 clean needles in a given year. "But now they're only getting three a year each," Stuckler said.

Nullbasic is a mutant form of the HIV-1 Tat protein that was previously shown to strongly inhibit HIV-1 replication in non-hematopoietic cell lines by targeting three steps of HIV-1 replication: reverse transcription, transport of viral mRNA and transactivation of HIV-1 gene expression.

The Yale team’s “prime and pull” method is focused on exactly that. Working with mice, the researchers found a way to “prime” T cells to fight a certain kind of infection

through conventional vaccination that causes a system-wide immune response.

The “prime and pull” technique could potentially be used to combat any infectious agent that enters the body through any specific tissue--agents like the human immunodeficiency virus (HIV) that causes AIDS.

Dr. Montelaro and his colleagues found that a particular sequence of amino acids on the tail end of HIV allow the virus to "punch into" and infect cells. The team manufactured a synthetic and more efficient version of this sequence -- called engineered cationic antimicrobial peptides, or "eCAPs" -- that laboratory tests have shown to rapidly destroy bacteria that are otherwise resistant to most standard antibiotics.

Traditional antibiotics typically work by poisoning important metabolic processes after being taken up by the target bacteria, a process that may take hours, or days, to clear a bacterial infection. In contrast, the eCAPs are specifically attracted to the surface of target bacteria where they disrupt the bacterial membrane, causing death within seconds, or minutes.

eCAPs work well against biofilms

If the report is confirmed, the child born in Mississippi would be only the second well-documented case of a cure in the world

Typically a newborn with an infected mother would be given one or two drugs as a prophylactic measure. But Dr. Gay said that based on her experience, she almost immediately used a three-drug regimen aimed at treatment, not prophylaxis, not even waiting for the test results confirming infection.

Virus levels rapidly declined with treatment and were undetectable by the time the baby was a month old. That remained the case until the baby was 18 months old, after which the mother stopped coming to the hospital and stopped giving the drugs.

Health officials in Oklahoma are notifying 57 patients who tested positive for hepatitis C and three patients who tested positive for hepatitis B after visiting oral surgeon W. Scott Harrington's office in Tulsa and a city suburb, according to a joint statement issued Wednesday by the Oklahoma State Department of Health and the Tulsa Health Department.

Dental patients tested for HIV, hepatitis var currExpandable="expand25"; if(typeof CNN.expandableMap==='object'){CNN.expandableMap.push(currExpandable);} var mObj={}; mObj.type='video'; mObj.contentId=''; mObj.source='us/2013/03/29/sot-nr-colton-scott-hiv-hepatitis-dentist-harrington.cnn'; mObj.videoSource='CNN'; mObj.videoSourceUrl='http://newsroom.blogs.cnn.com/'; mObj.lgImage="http://i2.cdn.turner.com/cnn/dam/assets/130328181821-01-oklahoma-dentist-story-body.png"; mObj.lgImageX=300; mObj.lgImageY=169; mObj.origImageX="214"; mObj.origImageY="120"; mObj.contentType='video'; CNN.expElements.expand25Store=mObj;

Dentist's former patient: How could you? "This is a complex investigation," state epidemiologist Kristy Bradley said in the statement. "The next phase will include more in-depth interviews of persons who test positive to determine the likelihood that their exposure is associated with their dental surgical procedure at the Harrington practice. We will certainly continue to keep the public informed as we learn more." Mor

The researchers found these bacterial molecules in brain samples from people with HIV, as well as people with no known infectious disease but who had undergone brain surgery

If living bacteria help to maintain brain health in some way, disruptions to them, for example from antibiotics, could contribute to disease

For every death from AIDS, the US federal research establishment awards approximately $69,000 in grant funds. And for every death from MRSA, it awards $570.

MRSA, let’s remember, kills an estimated 19,000 Americans a year: more than HIV, and more than pneumococcal disease, meningococcal disease, H. influenzae and group A Streptococcus combined. 

because HIV has been a research priority for most of the 30 years of its existence, research has brought forth thousands of  antiviral compounds and drug combinations for treatment.

A new study finds that such transplants cured 15 of 16 people who had recurring infections with Clostridium difficile bacteria, whereas antibiotics cured only 3 of 13 and 4 of 13 patients in two comparison groups.